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performed by Mexican private consultants and 67.6% of the CEE presentations used
a decision tree-model or a Markov model. CONCLUSIONS: An increase of Mexican 
presentations at ISPOR meetings mainly promoted by local consultants and pharma-
ceutical companies with a medium methodological quality.
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OBJECTIVES: In order to assess health-related quality of life (HRQoL) among
Chinese-speaking populations, a number of HRQoL instruments originally developed
in English in North America or Europe were translated into Chinese over the past two
decades. The current study attempted to review the usage of Chinese versions of 
generic HRQoL instruments including SF-36, SF-12, SF-8, SF-6D, EQ-5D, HUI2,
HUI3, and QWB. METHODS: MEDLINE and ﬁ ve Chinese databases including CNKI 
(mainland China), CBM (mainland China), Wanfang (mainland China), CEPS
(Taiwan), and HKInChiP (Hong Kong & Macau) were searched up to December 2008
for HRQoL studies in Chinese-speaking populations. RESULTS: A total of 1341 rel-
evant original research papers were identiﬁ ed. Approximately three-quarters (73.90%)
of papers were published in Chinese journals. The vast majority of papers (91.50%) 
were published after the year of 2002. In terms of the number of papers, the top three
frequently used generic HRQoL instruments were SF-36 (n  1281), EQ-5D (n  30),
and SF-12 (n  28). One thousand and sixty-two papers reported HRQoL measured
in patient populations, with circulatory diseases being the most frequently studied 
therapeutic areas (n  195). Geographically, identiﬁ ed studies were mainly conducted 
in mainland China (n  1012), followed by Taiwan (n  149), Hong Kong (n  112), 
Singapore (n  53), U.S. (n  10), Canada (n  4) and Australia (n  1). Except for 
Singapore where the majority of studies were used to evaluate instruments, generic 
HRQoL instruments were mainly used to measure quality of life in other countries or 
districts. CONCLUSIONS: There is a growing body of English and Chinese literature 
on the measurement of HRQoL using generic HRQoL instruments in Chinese-
speaking populations. For better assessment of Chinese-speaking populations, the
appropriateness of existing generic HRQoL instruments should be further evaluated
in the future.
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OBJECTIVES: To develop process indicators for assessing the quality of care in the
23 Primary Care Groups (PCGs) of the Local Health Unit (LHU) of Reggio Emilia,
Italy, using administrative data. METHODS: Data were extracted from the 2006 
Reggio Emilia LHU Healthcare database, including demographic, hospital, outpatient 
pharmacy, and outpatient specialty data on all residents, as well as information about 
each LHU General Practitioner (GP). We retrieved information on approximately
450,000 LHU residents and on 343 GPs and their PCG of practice. We included GPs
who practiced for the whole year in only one PCG. The sample patient population
comprised individuals who were residents in the LHU for the whole year and did
not change their GP during the year. Initially developed based on a literature review,
the quality indicators were deﬁ ned jointly by the project team and leaders of the 23
PCGs. For each indicator, we computed the proportion of eligible patients within each 
PCG who received the recommended care. RESULTS: A total of 340 GPs (99.1%)
met the inclusion criteria. These GPs had a total number of 383,772 continuously 
enrolled patients for 2006. The number of GPs per PCG ranged from 4 to 28 and the
number of patients per PCG varied from 3,862 to 30,855. Nine quality care indicators
covering cardiovascular, diabetes, and asthma management were identiﬁ ed. Analyses 
of the indicators exhibited signiﬁ cant variation among the PCGs. For example, the
proportion of post-myocardial infarction patients receiving beta-blockers varied from 
33.3% to 90.9% across the PCGs. CONCLUSIONS: Quality of care provided by
Italy’s family physician practices can be assessed using administrative data. For the
indicators adopted, study ﬁ ndings showed a considerable variation in medical patterns 
among PCGs. These results provide LHU policy makers and PCGs with relevant
information to establish quality improvement initiatives targeted at the individual 
practice level.
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OBJECTIVES: The purpose of the study was to measure the extent of pharmacoeco-
nomics education (PE) in non-US colleges of pharmacy. METHODS: Two surveys
were used. Survey 1 was e-mailed or faxed to over 700 colleges of pharmacy, obtained 
from the International Pharmaceutical Federation Website or through Medline and
Google Searches, asking respondents if pharmacoeconomics was taught in their 
college. Survey 2 was sent to respondents who taught PE asking: 1) number of class-
room hours devoted to PE 2) whether these were in a required or elective course 3)
number of students in the course 4) topics covered 5) resources (books/articles) used.
RESULTS: Ninety-eight schools responded to Survey 1. Pharmacoeconomics educa-
tion was offered at 62 (63%) of these 98 colleges. The response rate for Survey 2 was 
52% (n  33). However 3 colleges did not provide complete data, leaving data on 30
colleges for this analysis. Twenty-six (87%) colleges indicated that pharmacoeconom-
ics was taught as a required course, 2 (7%) indicated that it was offered as an elective 
course, and 2 (7%) indicated that PE was taught as both a required and elective course. 
The median number of required hours was 16 (std dev  150). The number of elective 
hours ranged from 3 to 45 with a median of 27 (std dev  19). The mean number of 
students taking pharmacoeconomics as a required course was 104 (std dev  60; 
median  90, range 12–250). “Types of pharmacoeconomic analyses” (i.e., comparing
CBA, CEA, CMA, CUA) was the most common topic taught. Several articles and 
books were provided as resources. A comparison of these results to similar studies
conducted previously will be provided. CONCLUSIONS: Correct and current contact 
information for international pharmacy schools was difﬁ cult to obtain, and obtaining 
high response rates was also challenging. In this study, both e-mails and facsimiles
were used to increase response rates.
HEALTH CARE USE & POLICY STUDIES – Health Technology
Assessment Programs
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OBJECTIVES: To explore the present the process followed to implement technologies 
in the public health sector from the perspective of key decision makers. The Spanish
National Health System (NHS) is decentralized, and most management is decided in
the seventeen Autonomous Communities (AC). Several health technology evaluation
agencies (HTEA) have been established countrywide. The literature shows that 
im plementation ‘technologies’ remains far from ideal in Spain (Gonzalez B, 2007).
METHODS: A naturalistic, qualitative study was conducted. Semi-structured inter-
views with key decision makers across country, including senior health managers at
the Autonomous Communities’ Departments of Health (macro-level of decision), 
Hospitals’ managers and directors (meso-level), Heads of clinical services (micro-level 
of decision), and experts on health services’ research and evaluation were carried out 
to explore their views on the present of the implementation of technologies in the 
health system. Data interviews data were collected until different categories of infor-
mation was saturated. The grounded theory method was applied to categorize the 
information gathered. RESULTS: A total of 35 interviews were conducted, including 
managers, researchers and evaluators. Eight categories of information emerged: 1) the 
industry’s inputs to the NHS, contributing to its modernization; 2) the assessment of 
technologies, based on safety and efﬁ cacy while leaving behind effectiveness, efﬁ ciency 
or cost-beneﬁ t; 3) implementation processes, relying on informal mechanisms and 
variable criteria; 4) the gap, between legal statements and existing practices; 5) HTEA 
reports’, of scarce impact on managers’ decisions; 6) ﬁ nancing mechanisms, that one 
barely effective in responding to technological progresses; 7) the industry, seen as a 
self-centered NHS provider making little efforts to realistically show the “pros and
cons” of technologies; 8) the need for transparency, openness and consensus amongst
all involved. CONCLUSIONS: Major opportunities for improvement in the imple-
mentation of technologies in the NHS exist. These ﬁ ndings set the basis for exploring
strategies to enhance the future scenario.
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OBJECTIVES: The quality of evidence used by manufacturers in submissions to HTA 
agencies is an important determinant of a positive appraisal. In 2008, NICE revised 
guidelines and added a section on indirect synthesis methods. The study objective was 
to evaluate previous trends and understand past and evolving inﬂ uences of method-
ological factors, particularly indirect and mixed treatment comparisons, on submission 
outcome. METHODS: A landscape review was conducted of NICE submission meth-
odologies and appraisal outcome, with focus on the use of indirect comparison. Key 
data were extracted from NICE/ ERG documents for all NICE appraisals (2003-
August 2008). Also, case studies were investigated in rheumatoid arthritis, osteopo-
rosis, bone metastases and oncology. Key ﬁ ndings and recommendations for submission 
preparation, with focus on indirect comparison use, are presented. RESULTS: The 
number of indirect comparisons used in appraisals has increased from 2 to 8 between
2005 and 2008. The proportions of published NICE appraisals mentioning indirect 
comparisons to total appraisals were 2/7 (2005), 2/18 (2006), 7/21 (2007) and August 
2/18 to August 2008. Indirect comparison, historically, used primarily in oncology, is 
increasingly being implemented in other therapeutic areas. However, 81% of NICE 
submissions that included indirect comparison have been recommended, compared 
with 86% that did not include indirect comparison. NICE critique of indirect com-
parisons across submissions focused on the lack of clear justiﬁ cation of methodology,
assumptions, and comparators used, along with management of clinical and statistical 
heterogeneity. Further, case studies have shown the need to avoid non-validated 
methods and distant indirect comparisons. CONCLUSIONS: Where head-to-head 
